210 related articles for article (PubMed ID: 18382891)
1. MT3-MMP (MMP-16) is downregulated by in vitro cytokine stimulation of cartilage, but unaltered in naturally occurring equine osteoarthritis and osteochondrosis.
Garvican ER; Vaughan-Thomas A; Redmond C; Clegg PD
Connect Tissue Res; 2008; 49(2):62-7. PubMed ID: 18382891
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo.
Hui W; Rowan AD; Richards CD; Cawston TE
Arthritis Rheum; 2003 Dec; 48(12):3404-18. PubMed ID: 14673992
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
Ohta S; Imai K; Yamashita K; Matsumoto T; Azumano I; Okada Y
Lab Invest; 1998 Jan; 78(1):79-87. PubMed ID: 9461124
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic ultrasound effects on interleukin-1beta stimulated cartilage construct in vitro.
Park K; Hoffmeister B; Han DK; Hasty K
Ultrasound Med Biol; 2007 Feb; 33(2):286-95. PubMed ID: 17207905
[TBL] [Abstract][Full Text] [Related]
6. IL-10 overexpression differentially affects cartilage matrix gene expression in response to TNF-alpha in human articular chondrocytes in vitro.
Müller RD; John T; Kohl B; Oberholzer A; Gust T; Hostmann A; Hellmuth M; Laface D; Hutchins B; Laube G; Veh RW; Tschoeke SK; Ertel W; Schulze-Tanzil G
Cytokine; 2008 Dec; 44(3):377-85. PubMed ID: 19026560
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the catabolic effects of interleukin-1beta on proteoglycan metabolism in equine cartilage cocultured with synoviocytes.
Gregg AJ; Fortier LA; Mohammed HO; Mayr KG; Miller BJ; Haupt JL
Am J Vet Res; 2006 Jun; 67(6):957-62. PubMed ID: 16740087
[TBL] [Abstract][Full Text] [Related]
8. Chondrocytes harvested from osteochondritis dissecans cartilage are able to undergo limited in vitro chondrogenesis despite having perturbations of cell phenotype in vivo.
Garvican ER; Vaughan-Thomas A; Redmond C; Clegg PD
J Orthop Res; 2008 Aug; 26(8):1133-40. PubMed ID: 18327793
[TBL] [Abstract][Full Text] [Related]
9. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.
Tung JT; Fenton JI; Arnold C; Alexander L; Yuzbasiyan-Gurkan V; Venta PJ; Peters TL; Orth MW; Richardson DW; Caron JP
Can J Vet Res; 2002 Jan; 66(1):19-25. PubMed ID: 11858644
[TBL] [Abstract][Full Text] [Related]
10. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
12. Quantification of cytokines and inflammatory mediators in a three-dimensional model of inflammatory arthritis.
Rai MF; Rachakonda PS; Manning K; Vorwerk B; Brunnberg L; Kohn B; Schmidt MF
Cytokine; 2008 Apr; 42(1):8-17. PubMed ID: 18343681
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cartilage degradation effects of matrix metalloproteinase-13 in equine cartilage cocultured with synoviocytes.
Fortier LA; Schnabel LV; Mohammed HO; Mayr KG
Am J Vet Res; 2007 Apr; 68(4):379-84. PubMed ID: 17397292
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations.
Jouglin M; Robert C; Valette JP; Gavard F; Quintin-Colonna F; Denoix JM
Vet Res; 2000; 31(5):507-15. PubMed ID: 11050746
[TBL] [Abstract][Full Text] [Related]
15. Gross, histologic, and gene expression characteristics of osteoarthritic articular cartilage of the metacarpal condyle of horses.
Smith KJ; Bertone AL; Weisbrode SE; Radmacher M
Am J Vet Res; 2006 Aug; 67(8):1299-306. PubMed ID: 16881840
[TBL] [Abstract][Full Text] [Related]
16. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
Sondergaard BC; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal MA
Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
[TBL] [Abstract][Full Text] [Related]
17. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
18. Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes.
Liacini A; Sylvester J; Li WQ; Zafarullah M
Arthritis Res Ther; 2005; 7(4):R777-83. PubMed ID: 15987479
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints.
Chubinskaya S; Kuettner KE; Cole AA
Lab Invest; 1999 Dec; 79(12):1669-77. PubMed ID: 10616215
[TBL] [Abstract][Full Text] [Related]
20. MMP-mediated collagen breakdown induced by activated protein C in equine cartilage is reduced by corticosteroids.
Garvican ER; Vaughan-Thomas A; Redmond C; Gabriel N; Clegg PD
J Orthop Res; 2010 Mar; 28(3):370-8. PubMed ID: 19777546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
